Clinical Trials Directory

Trials / Unknown

UnknownNCT03102268

ncRNAs in Exosomes of Cholangiocarcinoma

Exosomes-derived ncRNAs As Biomarkers In Cholangiocarcinoma Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
The Second Hospital of Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Exosomes are part of extracellular vesicles(EVs), and can be secreted into the environment by many types of cells. It has been demonstrated that the content and function of exosomes depends on the originating cell and the conditions under which they are produced.Exosomes contain proteins,RNAs and lipid,which may transfer biological information and activities from donor cells to receptor cells. Non-coding RNAs are involved in many biological activities including tumor growth and metastasis. In this prospective translational study, preclinical and clinical phases have been designed. On the first step, the main goal is to characterize the ncRNAs of cholangiocarcinoma derived exosomes. This exosome biomarker may provide a useful diagnostic tool. As a second step, the study will evaluate the prognostic and predictive value of cholangiocarcinoma exosomes levels in plasma in a prospectively recruited cohort of cholangiocarcinoma patients before and after surgical resection.

Conditions

Timeline

Start date
2017-05-01
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2017-04-05
Last updated
2017-04-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03102268. Inclusion in this directory is not an endorsement.